These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 31578349)

  • 1. Chemical proteomics reveals target selectivity of clinical Jak inhibitors in human primary cells.
    Eberl HC; Werner T; Reinhard FB; Lehmann S; Thomson D; Chen P; Zhang C; Rau C; Muelbaier M; Drewes G; Drewry D; Bantscheff M
    Sci Rep; 2019 Oct; 9(1):14159. PubMed ID: 31578349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors.
    Bantscheff M; Eberhard D; Abraham Y; Bastuck S; Boesche M; Hobson S; Mathieson T; Perrin J; Raida M; Rau C; Reader V; Sweetman G; Bauer A; Bouwmeester T; Hopf C; Kruse U; Neubauer G; Ramsden N; Rick J; Kuster B; Drewes G
    Nat Biotechnol; 2007 Sep; 25(9):1035-44. PubMed ID: 17721511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimized chemical proteomics assay for kinase inhibitor profiling.
    Médard G; Pachl F; Ruprecht B; Klaeger S; Heinzlmeir S; Helm D; Qiao H; Ku X; Wilhelm M; Kuehne T; Wu Z; Dittmann A; Hopf C; Kramer K; Kuster B
    J Proteome Res; 2015 Mar; 14(3):1574-86. PubMed ID: 25660469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity-Based Protein Profiling Reveals Potential Dasatinib Targets in Gastric Cancer.
    Choi KM; Cho E; Bang G; Lee SJ; Kim B; Kim JH; Park SG; Han EH; Chung YH; Kim JY; Kim E; Kim JY
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33291786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing immobilized kinase inhibitors and covalent ATP probes for proteomic profiling of kinase expression and drug selectivity.
    Lemeer S; Zörgiebel C; Ruprecht B; Kohl K; Kuster B
    J Proteome Res; 2013 Apr; 12(4):1723-31. PubMed ID: 23495751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential Kinobeads Profiling for Target Identification of Irreversible Kinase Inhibitors.
    Dittus L; Werner T; Muelbaier M; Bantscheff M
    ACS Chem Biol; 2017 Oct; 12(10):2515-2521. PubMed ID: 28876896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Competitive Kinase Enrichment Proteomics Reveals that Abemaciclib Inhibits GSK3β and Activates WNT Signaling.
    Cousins EM; Goldfarb D; Yan F; Roques J; Darr D; Johnson GL; Major MB
    Mol Cancer Res; 2018 Feb; 16(2):333-344. PubMed ID: 29133594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-based proteome profiling of potential dasatinib targets by use of affinity-based probes.
    Shi H; Zhang CJ; Chen GY; Yao SQ
    J Am Chem Soc; 2012 Feb; 134(6):3001-14. PubMed ID: 22242683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comprehensive target selectivity survey of the BCR-ABL kinase inhibitor INNO-406 by kinase profiling and chemical proteomics in chronic myeloid leukemia cells.
    Rix U; Remsing Rix LL; Terker AS; Fernbach NV; Hantschel O; Planyavsky M; Breitwieser FP; Herrmann H; Colinge J; Bennett KL; Augustin M; Till JH; Heinrich MC; Valent P; Superti-Furga G
    Leukemia; 2010 Jan; 24(1):44-50. PubMed ID: 19890374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New affinity probe targeting VEGF receptors for kinase inhibitor selectivity profiling by chemical proteomics.
    Ku X; Heinzlmeir S; Helm D; Médard G; Kuster B
    J Proteome Res; 2014 May; 13(5):2445-52. PubMed ID: 24712744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring Cell-surface
    Kalxdorf M; Gade S; Eberl HC; Bantscheff M
    Mol Cell Proteomics; 2017 May; 16(5):770-785. PubMed ID: 28336715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Affinity Enrichment Chemoproteomics for Target Deconvolution and Selectivity Profiling.
    Werner T; Steidel M; Eberl HC; Bantscheff M
    Methods Mol Biol; 2021; 2228():237-252. PubMed ID: 33950495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global target profile of the kinase inhibitor bosutinib in primary chronic myeloid leukemia cells.
    Remsing Rix LL; Rix U; Colinge J; Hantschel O; Bennett KL; Stranzl T; Müller A; Baumgartner C; Valent P; Augustin M; Till JH; Superti-Furga G
    Leukemia; 2009 Mar; 23(3):477-85. PubMed ID: 19039322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the novel broad-spectrum kinase inhibitor CTx-0294885 as an affinity reagent for mass spectrometry-based kinome profiling.
    Zhang L; Holmes IP; Hochgräfe F; Walker SR; Ali NA; Humphrey ES; Wu J; de Silva M; Kersten WJ; Connor T; Falk H; Allan L; Street IP; Bentley JD; Pilling PA; Monahan BJ; Peat TS; Daly RJ
    J Proteome Res; 2013 Jul; 12(7):3104-16. PubMed ID: 23692254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational proteomics of biomolecular interactions in the sequence and structure space of the tyrosine kinome: deciphering the molecular basis of the kinase inhibitors selectivity.
    Verkhivker GM
    Proteins; 2007 Mar; 66(4):912-29. PubMed ID: 17173284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoproteomic characterization of protein kinase inhibitors using immobilized ATP.
    Duncan JS; Haystead TA; Litchfield DW
    Methods Mol Biol; 2012; 795():119-34. PubMed ID: 21960219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical proteomics and functional proteomics strategies for protein kinase inhibitor validation and protein kinase substrate identification: applications to protein kinase CK2.
    Gyenis L; Turowec JP; Bretner M; Litchfield DW
    Biochim Biophys Acta; 2013 Jul; 1834(7):1352-8. PubMed ID: 23416530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemoproteomic Selectivity Profiling of PIKK and PI3K Kinase Inhibitors.
    Reinecke M; Ruprecht B; Poser S; Wiechmann S; Wilhelm M; Heinzlmeir S; Kuster B; Médard G
    ACS Chem Biol; 2019 Apr; 14(4):655-664. PubMed ID: 30901187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dasatinib, imatinib and staurosporine capture compounds - Complementary tools for the profiling of kinases by Capture Compound Mass Spectrometry (CCMS).
    Fischer JJ; Dalhoff C; Schrey AK; Graebner OY; Michaelis S; Andrich K; Glinski M; Kroll F; Sefkow M; Dreger M; Koester H
    J Proteomics; 2011 Dec; 75(1):160-8. PubMed ID: 21664307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinobead and Single-Shot LC-MS Profiling Identifies Selective PKD Inhibitors.
    Golkowski M; Vidadala RS; Lombard CK; Suh HW; Maly DJ; Ong SE
    J Proteome Res; 2017 Mar; 16(3):1216-1227. PubMed ID: 28102076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.